JAK-STAT intracellular pathway inhibitors (CEAMED)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameJAK-STAT intracellular pathway inhibitors (CEAMED)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionJanus kinase inhibitorsSTAT transcription factors inhibitors
TargetsJanus kinaseSTAT transcription factors
Therapy Area/IndicationsInflammationDiabetes MellitusNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCEAMED SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCEAMED SA
Active IndicationsN/A
Inactive IndicationsInflammationDiabetes MellitusNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A